Early innovation at BMS

Learn how Bristol Myers Squibb advances early innovation by collaborating with researchers, entrepreneurs, and partners to discover and develop breakthrough therapies for patients.

Early Innovation at BMS

Our commitment to R&D innovation goes beyond internal drug discovery and our vast network of external partnerships. To accelerate the next wave of scientific breakthroughs, we also support life science startups and aspiring biotech entrepreneurs through a diverse and growing array of programs in the U.S. and abroad. 

BMS sponsored/affiliated incubators

BMS collaborates and supports a variety of incubators globally. All with a shared vision to create, support and accelerate early entrepreneurial biotech companies that share our vision of transforming patient’s lives through science. They act as launch pads for life sciences and biotech startups and provide a collaborative space that gives entrepreneurs the playground to be creative and build innovative life sciences businesses.

North America

NameLocationWeb Site
LabCentralCambridge, MAhttps://labcentral.org
BioLabs@NYU LangoneNYC, NYhttps://www.biolabs.io/nyulangone
MBC BioLabsSan Francisco, CAhttps://mbcbiolabs.com

Europe & Middle East

NameLocationWeb Site
BioPoleLausanne, Switzerlandhttps://www.biopole.ch
IncentiveIsraelhttps://www.incentive-il.com
LAB282Oxford, UKhttps://www.lab282.org
beLAB1407Northern UKhttps://belab1407.org
beLAB2122Germany  https://belab2122.org